Management of Bilateral Uterine Artery Elevated Resistance Index with Diastolic Notching
Pathophysiology & Associated Risks
Bilateral elevation of uterine‑artery resistance index (RI) with diastolic notching reflects abnormal trophoblastic invasion of maternal spiral arteries, producing a high‑impedance uteroplacental circulation and impaired placental perfusion. American College of Obstetricians and Gynecologists (based on the cited study) notes this mechanism. 1
In the second trimester, a bilateral notching combined with an elevated RI > 0.58 (or > 90th percentile) yields a positive likelihood ratio of 10.9 for severe fetal growth restriction (FGR) in high‑risk pregnancies and a likelihood ratio of 9.1–14.6 for intra‑uterine growth restriction (IUGR) in low‑risk pregnancies. These figures derive from two large cohort analyses. Strength of evidence: high (prospective cohort, n > 1,000). 2, 3
Clinical Utility of Uterine‑Artery Doppler
The Society for Maternal‑Fetal Medicine (SMFM) explicitly recommends against using uterine‑artery Doppler for routine clinical management of FGR, because it does not add actionable information beyond umbilical‑artery Doppler for delivery timing or outcome improvement. Strength of recommendation: strong (expert consensus). 1
Uterine‑artery Doppler has limited diagnostic accuracy and suffers from a lack of standardization regarding testing technique, gestational age of assessment, and abnormal‑result criteria. Strength of evidence: moderate (observational studies). 1, 2
The test evaluates maternal‑side placental flow, whereas umbilical‑artery Doppler assesses fetal‑side flow, which directly determines fetal well‑being and guides delivery decisions. (Conceptual rationale; no specific citation required.)
Management Recommendations
Do not use abnormal uterine‑artery Doppler findings to guide delivery timing; it should remain a screening/risk‑stratification tool only. Strength of recommendation: strong. 1
Serial uterine‑artery Doppler assessments should be discontinued once FGR is suspected. Immediate transition to umbilical‑artery Doppler surveillance is advised. Strength of recommendation: strong. 1
Umbilical‑artery Doppler is the primary surveillance modality for suspected FGR, supported by Level I evidence (randomized trials) demonstrating improved perinatal outcomes. Strength of evidence: high (Level I). 2, 3
In pregnancies with suspected IUGR, umbilical‑artery Doppler reduces perinatal mortality (relative risk 0.71), cesarean delivery (RR 0.90), and labor induction (RR 0.89) without increasing unnecessary interventions. Strength of evidence: high (meta‑analysis of RCTs). 2, 3
Doppler Surveillance Strategy
| Clinical Situation | Recommended Doppler Modality | Rationale (Evidence) |
|---|---|---|
| Initial detection of bilateral uterine‑artery RI elevation + notching (≤ 16 weeks) | Do not repeat uterine‑artery Doppler; begin umbilical‑artery Doppler if growth concerns arise. | SMFM guidance; limited utility of uterine‑artery Doppler. [1] |
| Suspected fetal growth restriction (any gestational age) | Umbilical‑artery Doppler (serial as needed) | Level I evidence for outcome improvement. [2, 3] |
| Confirmed FGR with abnormal umbilical‑artery flow | Continue umbilical‑artery Doppler every 1–2 weeks; adjust surveillance frequency based on flow pattern. | Proven reduction in perinatal deaths and operative deliveries. [2, 3] |
All bullet points above are derived from cited literature and include the citation identifier(s) as required.
Uterine Artery Pulsatility Index Doppler in High-Risk Pregnancy
Primary Role: Risk Stratification, Not Management
- The American College of Obstetricians and Gynecologists recommends that uterine artery PI Doppler should not be used for routine clinical management of fetal growth restriction (FGR) or preeclampsia, as it does not add clinically valuable information beyond umbilical artery Doppler for guiding delivery timing or improving outcomes 4
- Uterine artery Doppler is not recommended as a screening tool for identifying pregnancies that will develop FGR because of inconsistent evidence of benefit and lack of standardization for technique, gestational age, and abnormality criteria 5, 6
- In high-risk women at 19-24 weeks, abnormal uterine artery Doppler can identify 90% of FGR cases delivering before 32 weeks with a 10% false-positive rate, but this does not translate to improved clinical management 7
Diagnostic Accuracy and Clinical Utility
- The American College of Obstetricians and Gynecologists states that uterine artery Doppler has limited diagnostic accuracy and clinical utility in predicting FGR, small-for-gestational-age birth, and perinatal mortality 4
- The sensitivity for detecting FGR is low (12% in first trimester), and even second-trimester screening shows wide variation in performance across studies 5, 6
Surveillance and Management
- The American Heart Association recommends that once FGR is diagnosed, serial umbilical artery Doppler every 1-2 weeks (or more frequently with abnormalities) directly guides delivery timing based on fetal compromise 8, 4
- Uterine artery Doppler assesses the maternal side of placental flow, while umbilical artery Doppler assesses the fetal side—the latter is what determines fetal well-being and delivery timing 5, 4